Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “antibody”

426 pharma patents match "antibody" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 426
Index total 30,257
Page 17 / 18

Quick answer

This filtered view shows 426 pharmaceutical patents matching "antibody" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

426 results for “antibody” · 30,257 patents in full index Clear search

  1. US 7342105

    Antibody and use thereof

    Takeda Chemical Industries Ltd. · Granted Mar 11, 2008 · Expires Mar 6, 2028

    granted
  2. US 7335477

    Truncated recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines

    United States of America as represented by the Secretary of the Air Force · Granted Feb 26, 2008 · Expires Feb 21, 2028

    granted
  3. US 7332585

    Bispecific single chain Fv antibody molecules and methods of use thereof

    The Regents of the California University · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted
  4. US 7285639

    Antibody to telomerase reverse transcriptase

    The Regents of the University of Colorado · Granted Oct 23, 2007 · Expires Oct 18, 2027

    granted
  5. US 7256004

    Variants of humanized anti-carcinoma monoclonal antibody CC49

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 14, 2007 · Expires Aug 9, 2027

    granted
  6. US 7247303

    Selected antibody CDRs for binding to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Jul 24, 2007 · Expires Jul 19, 2027

    granted
  7. US 7173112

    Antibody to GALP and uses thereof

    Takeda Pharmaceutical Company Limited · Granted Feb 6, 2007 · Expires Feb 1, 2027

    granted
  8. US 7153509

    Immunogenic peptides comprising a T-helper epitope and a B-cell neutralizing antibody epitope

    The Regents of the University of California · Granted Dec 26, 2006 · Expires Dec 21, 2026

    granted
  9. US 7094883

    Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein

    The United States of America as represented by the Secretary of the Army · Granted Aug 22, 2006 · Expires Aug 17, 2026

    granted
  10. US 7094405

    Peptides which elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response and T helper cell response in a broad range of MHC type recipients

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 22, 2006 · Expires Aug 17, 2026

    granted
  11. US 7056509

    Antibody methods for selectively inhibiting VEGF

    The Board of Regents of the University of Texas System · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  12. US 6889145

    Three-dimensional model of a Fc region of an IgE antibody and uses thereof

    Northwestern University · Granted May 3, 2005 · Expires Apr 28, 2025

    expired
  13. US 6887468

    Antibody kits for selectively inhibiting VEGF

    The Board of Regents of the University of Texas System · Granted May 3, 2005 · Expires Apr 28, 2025

    expired
  14. US 6818749

    Variants of humanized anti carcinoma monoclonal antibody cc49

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 16, 2004 · Expires Nov 11, 2024

    expired
  15. US 6703020

    Antibody conjugate methods for selectively inhibiting VEGF

    The Board of Regents of the University of Texas System · Granted Mar 9, 2004 · Expires Mar 4, 2024

    expired
  16. US 6699674

    Expression and refolding of truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi and its use in antibody based detection assays and vaccines

    United States of America as represented by the Secretary of the Air Force · Granted Mar 2, 2004 · Expires Feb 26, 2024

    expired
  17. US 6689362

    Method for treating T-lineage leukemias and lymphomas using a CD7-specific monoclonal antibody (TXU-7) linked to the pokeweed antiviral protein (PAP)

    Regents of the University of Minnesota · Granted Feb 10, 2004 · Expires Feb 5, 2024

    expired
  18. US 6676941

    Antibody conjugate formulations for selectively inhibiting VEGF

    The Board of Regents of the University of Texas System · Granted Jan 13, 2004 · Expires Jan 8, 2024

    expired
  19. US 6573236

    Inhibiting MOG-antibody binding

    The Regents of the University of California · Granted Jun 3, 2003 · Expires May 29, 2023

    expired
  20. US 6573058

    Antibody to herpes virus entry receptor protein

    Northwestern University · Granted Jun 3, 2003 · Expires May 29, 2023

    expired
  21. US 6569431

    Recombinant antibody fragments as autoantibody antagonists

    The Regents of the University of California · Granted May 27, 2003 · Expires May 22, 2023

    expired
  22. US 6524583

    Antibody methods for selectively inhibiting VEGF

    The Board of Regents of the University of Texas System · Granted Feb 25, 2003 · Expires Feb 20, 2023

    expired
  23. US 6482415

    Expression and refolding of truncated recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi and its use in antibody based detection assays and vaccines

    United States of America as represented by the Secretary of the Air Force · Granted Nov 19, 2002 · Expires Nov 14, 2022

    expired
  24. US 6416758

    Antibody conjugate kits for selectively inhibiting VEGF

    Boards of Regents, The University of Texas System · Granted Jul 9, 2002 · Expires Jul 4, 2022

    expired